Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow

M. Lim, Y. Pang, S. Ma, S. Hao, H. Shi, Y. Zheng, C. Hua, X. Gu, Feng-Chun Yang, W. Yuan, T. Cheng

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Degeneration of normal hematopoietic cells is a shared feature of malignant diseases in the hematopoietic system. Previous studies have shown the exhaustion of hematopoietic progenitor cells (HPCs) in leukemic marrow, whereas hematopoietic stem cells (HSCs) remain functional upon relocation to non-leukemic marrow. However, the underlying cellular mechanisms, especially the specific niche components that are responsible for the degeneration of HPCs, are unknown. In this study, we focused on murine bone mesenchymal stem cells (MSCs) and their supporting function for normal hematopoietic cells in Notch1-induced acute T-cell lymphocytic leukemia (T-ALL) mice. We demonstrate that the proliferative capability and differentiation potential of T-ALL MSCs were impaired due to accelerated cellular senescence. RNA-seq analysis revealed significant transcriptional alterations in leukemic MSCs. After co-cultured with the MSCs from T-ALL mice, a specific inhibitory effect on HPCs was defined, whereas in vivo repopulating potential of normal HSCs was not compromised. Furthermore, osteoprotegerin was identified as a cytokine to improve the function of T-ALL MSCs and to enhance normal HPC output via the p38/ERK pathway. Therefore, this study reveals a novel cellular mechanism underlying the inhibition of HPC generation in T-ALL. Leukemic MSCs may serve as a cellular target for improving normal hematopoietic regeneration therapeutically.

Original languageEnglish (US)
Pages (from-to)154-162
Number of pages9
JournalLeukemia
Volume30
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Hematopoietic Stem Cells
Mesenchymal Stromal Cells
Bone Marrow
Hematopoietic System
Osteoprotegerin
MAP Kinase Signaling System
Cell Aging
Regeneration
RNA
Cytokines
Bone and Bones

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow. / Lim, M.; Pang, Y.; Ma, S.; Hao, S.; Shi, H.; Zheng, Y.; Hua, C.; Gu, X.; Yang, Feng-Chun; Yuan, W.; Cheng, T.

In: Leukemia, Vol. 30, No. 1, 01.01.2016, p. 154-162.

Research output: Contribution to journalArticle

Lim, M, Pang, Y, Ma, S, Hao, S, Shi, H, Zheng, Y, Hua, C, Gu, X, Yang, F-C, Yuan, W & Cheng, T 2016, 'Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow', Leukemia, vol. 30, no. 1, pp. 154-162. https://doi.org/10.1038/leu.2015.210
Lim, M. ; Pang, Y. ; Ma, S. ; Hao, S. ; Shi, H. ; Zheng, Y. ; Hua, C. ; Gu, X. ; Yang, Feng-Chun ; Yuan, W. ; Cheng, T. / Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow. In: Leukemia. 2016 ; Vol. 30, No. 1. pp. 154-162.
@article{ece76256a88b4fed99e3d5c09d5732f7,
title = "Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow",
abstract = "Degeneration of normal hematopoietic cells is a shared feature of malignant diseases in the hematopoietic system. Previous studies have shown the exhaustion of hematopoietic progenitor cells (HPCs) in leukemic marrow, whereas hematopoietic stem cells (HSCs) remain functional upon relocation to non-leukemic marrow. However, the underlying cellular mechanisms, especially the specific niche components that are responsible for the degeneration of HPCs, are unknown. In this study, we focused on murine bone mesenchymal stem cells (MSCs) and their supporting function for normal hematopoietic cells in Notch1-induced acute T-cell lymphocytic leukemia (T-ALL) mice. We demonstrate that the proliferative capability and differentiation potential of T-ALL MSCs were impaired due to accelerated cellular senescence. RNA-seq analysis revealed significant transcriptional alterations in leukemic MSCs. After co-cultured with the MSCs from T-ALL mice, a specific inhibitory effect on HPCs was defined, whereas in vivo repopulating potential of normal HSCs was not compromised. Furthermore, osteoprotegerin was identified as a cytokine to improve the function of T-ALL MSCs and to enhance normal HPC output via the p38/ERK pathway. Therefore, this study reveals a novel cellular mechanism underlying the inhibition of HPC generation in T-ALL. Leukemic MSCs may serve as a cellular target for improving normal hematopoietic regeneration therapeutically.",
author = "M. Lim and Y. Pang and S. Ma and S. Hao and H. Shi and Y. Zheng and C. Hua and X. Gu and Feng-Chun Yang and W. Yuan and T. Cheng",
year = "2016",
month = "1",
day = "1",
doi = "10.1038/leu.2015.210",
language = "English (US)",
volume = "30",
pages = "154--162",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow

AU - Lim, M.

AU - Pang, Y.

AU - Ma, S.

AU - Hao, S.

AU - Shi, H.

AU - Zheng, Y.

AU - Hua, C.

AU - Gu, X.

AU - Yang, Feng-Chun

AU - Yuan, W.

AU - Cheng, T.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Degeneration of normal hematopoietic cells is a shared feature of malignant diseases in the hematopoietic system. Previous studies have shown the exhaustion of hematopoietic progenitor cells (HPCs) in leukemic marrow, whereas hematopoietic stem cells (HSCs) remain functional upon relocation to non-leukemic marrow. However, the underlying cellular mechanisms, especially the specific niche components that are responsible for the degeneration of HPCs, are unknown. In this study, we focused on murine bone mesenchymal stem cells (MSCs) and their supporting function for normal hematopoietic cells in Notch1-induced acute T-cell lymphocytic leukemia (T-ALL) mice. We demonstrate that the proliferative capability and differentiation potential of T-ALL MSCs were impaired due to accelerated cellular senescence. RNA-seq analysis revealed significant transcriptional alterations in leukemic MSCs. After co-cultured with the MSCs from T-ALL mice, a specific inhibitory effect on HPCs was defined, whereas in vivo repopulating potential of normal HSCs was not compromised. Furthermore, osteoprotegerin was identified as a cytokine to improve the function of T-ALL MSCs and to enhance normal HPC output via the p38/ERK pathway. Therefore, this study reveals a novel cellular mechanism underlying the inhibition of HPC generation in T-ALL. Leukemic MSCs may serve as a cellular target for improving normal hematopoietic regeneration therapeutically.

AB - Degeneration of normal hematopoietic cells is a shared feature of malignant diseases in the hematopoietic system. Previous studies have shown the exhaustion of hematopoietic progenitor cells (HPCs) in leukemic marrow, whereas hematopoietic stem cells (HSCs) remain functional upon relocation to non-leukemic marrow. However, the underlying cellular mechanisms, especially the specific niche components that are responsible for the degeneration of HPCs, are unknown. In this study, we focused on murine bone mesenchymal stem cells (MSCs) and their supporting function for normal hematopoietic cells in Notch1-induced acute T-cell lymphocytic leukemia (T-ALL) mice. We demonstrate that the proliferative capability and differentiation potential of T-ALL MSCs were impaired due to accelerated cellular senescence. RNA-seq analysis revealed significant transcriptional alterations in leukemic MSCs. After co-cultured with the MSCs from T-ALL mice, a specific inhibitory effect on HPCs was defined, whereas in vivo repopulating potential of normal HSCs was not compromised. Furthermore, osteoprotegerin was identified as a cytokine to improve the function of T-ALL MSCs and to enhance normal HPC output via the p38/ERK pathway. Therefore, this study reveals a novel cellular mechanism underlying the inhibition of HPC generation in T-ALL. Leukemic MSCs may serve as a cellular target for improving normal hematopoietic regeneration therapeutically.

UR - http://www.scopus.com/inward/record.url?scp=84953351162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953351162&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.210

DO - 10.1038/leu.2015.210

M3 - Article

C2 - 26239199

AN - SCOPUS:84953351162

VL - 30

SP - 154

EP - 162

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -